stockrowKoninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) EBITDA
Koninklijke Philips N.V.'s EBITDA for fiscal 2025 was $2.9B, up 38.9% from $2.1B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.1B. Over the past ten years it has ranged from $1.2B (fiscal 2023) to $3.7B (fiscal 2020); the current reading is higher than 55% of that period. Koninklijke Philips N.V. ranks 6th of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $2.9B | 38.88% |
| FY2024 | $2.1B | 66.26% |
| FY2023 | $1.2B | (17.16%) |
| FY2022 | $1.5B | (32.61%) |
| FY2021 | $2.2B | (38.91%) |
| FY2020 | $3.7B | 4.00% |
| FY2019 | $3.5B | 6.18% |
| FY2018 | $3.3B | 14.74% |
| FY2017 | $2.9B | (17.82%) |
| FY2016 | $3.5B | 36.46% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $475.9M | (58.63%) |
| Jun 2026 | $1.2B | 94.22% |
| Mar 2026 | $592.2M | (33.61%) |
| Dec 2025 | $892.0M | 17.82% |
| 28 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| BSX Boston Scientific Corporation compare | $5.4B |
| GEHC GE HealthCare Technologies Inc. compare | $3.5B |
| PHG Koninklijke Philips N.V. | $3.1B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.6B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $2.3B |
| STE STERIS plc compare | $1.7B |
| EW Edwards Lifesciences Corporation compare | $1.6B |
| DXCM DexCom, Inc. compare | $1.5B |
| GKOS Glaukos Corporation compare | −$130.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PHG
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement